Unlock the potential of next-generation antibody therapeutics
Our aim is to help you optimize your downstream process for your next-generation antibody therapeutics. Explore valuable insights into the use of our affinity chromatography resins, which have been specifically developed to address the challenges associated with engineered monoclonal antibodies.
Articles
Overcoming Purification Challenges in Antibody Therapeutics Manufacturing with Subdomain-Specific Affinity Solution
Discover resins—developed to bind antibody subdomain regions—that can support the downstream process for a variety of antibody formats.
Monoclonal Antibody Aggregate Polish and Viral Clearance Using Hydrophobic-Interaction Chromatography
Gain insight into using HIC purification, including viral clearance data, for monoclonal antibodies requiring aggressive strategies for aggregate clearance.
Novel Hydrophobic Interaction Chromatography Resins for Next Generation Biotherapeutic Challenges
Learn how POROS HIC resins provide excellent resolution, capacity, and product recovery for a wide range of biomolecules.
Improving Aggregate Removal to Enhance Clinical Manufacturing of Mabs
Gain knowledge from this case study describing mAb aggregate removal using HIC in flow-through mode, resulting in improved process efficiency and productivity, compared to a mixed-mode bind-elute step.
Overcoming Purification Challenges in Antibody Therapeutics Manufacturing
Overcome the purification challenges presented by complex novel formats derived from conventional antibody structures, including Fab fragments, Fc-fusion proteins, and bispecifics.
Rapid Implementation of Novel Affinity Purification
Discover how a customer was able to rapidly implement antibody affinity resins into their commercial manufacturing process for a next-generation antibody therapeutic.
eBooks
Quality innovations in monoclonal antibody manufacturing
Discover solutions for common purification, analysis, and quality evaluation challenges when manufacturing modern antibody-derived therapies.
AAV Purification and Scale-Up
Explore innovative solutions that surmount technical hurdles and enhance downstream processes, producing high product yield at lower costs. {Image needs to be provided}
Purification Solutions for Therapeutic Antibodies
Learn about innovative purification tools to help maximize productivity of downstream processing of traditional and complex antibodies therapeutics.
Posters
Upgrade Monoclonal Antibody Purification Workflow with a New Source of Protein A Resin
Review application data of our new Protein A resin designed to help improve the productivity and efficiency of your antibody purification process.
Accelerating antibody drug development with subdomain-specific affinity chromatography
Explore application data of our subdomain-specific affinity portfolio developed to address purification challenges with novel antibody molecules.
Webinars
Beyond Standard Protein A Resin: Establishment of an Improved DSP Affinity Platform Step for Monoclonal Antibodies
Gain insight into the process design and optimization for novel and affinity chromatography in a monoclonal antibody platform.
Innovation of Novel Purification Strategies: A Case Study of Clusterin Scavenger Resins
Learn about a scavenging clusterin, a common protein found in monoclonal antibody manufacturing, and topics such as the platform process for generating specific VHH antibody-based ligands
Novel Purification Approaches to Streamline Manufacturing of Antibody-based Therapeutics
Discover our complete portfolio of innovative affinity capture and polish solutions to help you develop novel antibody molecules such as Fab fragments, Fc-fusion proteins and bi-specific antibodies.
The Way Forward in Antibody Therapeutics
See how antibody subdomain-specific affinity chromatography can improve the productivity of antibody therapeutics purification workflows.
For research use or further manufacturing. Not for diagnostic use or direct administration into humans or animals.